
Keytruda extends survival for women with an aggressive breast cancer
Adding the drug Keytruda to standard chemotherapy can extend the lives of some women with an aggressive form of breast cancer, a new study finds. The study involved women with advanced triple-negative breast cancer, a hard-to-treat form of the disease. Read more